Paper765100
Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.
Pinder RM and 4 others. Drugs, 1975. Cited by 179 papers, by iCite.
Cite this record
ConductScience Library. Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Papers, record 765100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/765100
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fenfluramine | Major topic |
| Obesity | Major topic |
| Adult | |
| Age Factors | |
| Analgesics | |
| Anticonvulsants | |
| Appetite Depressants | |
| Body Temperature | |
| Central Nervous System | |
| Child | |
| Diabetes Mellitus | |
| Drinking Behavior | |
| Drug Interactions | |
| Hemodynamics | |
| Humans | |
| Kinetics | |
| Mental Disorders | |
| Metabolism | |
| Skin Diseases | |
| Substance-Related Disorders |
Source PubMed
References213
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 768960 | A clinical trial of a new fenfluramine preparation (Ponderax PA). | Postgrad Med J | 1975 | https://conductscience.org/library/papers/768960 | PubMed |
| 2 | 768954 | Metabolic effects of fenfluramine--a double-blind study. | Postgrad Med J | 1975 | https://conductscience.org/library/papers/768954 | PubMed |
| 3 | 4931755 | A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients. | Br J Clin Pract | 1971 | https://conductscience.org/library/papers/4931755 | PubMed |
| 4 | 4894948 | Fenfluramine: study of its central action through its effects on sleep. | Int Z Klin Pharmakol Ther Toxikol | 1969 | https://conductscience.org/library/papers/4894948 | PubMed |
| 5 | 5133438 | EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers. | Psychopharmacologia | 1971 | https://conductscience.org/library/papers/5133438 | PubMed |
| 6 | 4704518 | Effect of fenfluramine on human growth hormone release. | Br Med J | 1973 | https://conductscience.org/library/papers/4704518 | PubMed |
| 7 | 4441770 | Proceedings: Effect of the (minus)- and (plus)-isomers of fenfluramine and norfenfluramine on glucose uptake by the isolated rat hemidiaphragm. | Br J Pharmacol | 1974 | https://conductscience.org/library/papers/4441770 | PubMed |
| 8 | 4397450 | Species-dependent effects of fenfluramine on the central nervous system. | J Pharm Pharmacol | 1971 | https://conductscience.org/library/papers/4397450 | PubMed |
| 9 | 4804456 | The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics. | Postgrad Med J | 1973 | https://conductscience.org/library/papers/4804456 | PubMed |
| 10 | 4418757 | Structure-activity relationships in psychotomimetic phenylalkylamines. | J Med Chem | 1974 | https://conductscience.org/library/papers/4418757 | PubMed |
| 11 | 5331182 | Treatment of refractory obesity with fenfluramine. | Br Med J | 1966 | https://conductscience.org/library/papers/5331182 | PubMed |
| 12 | 4717426 | Fenfluramine and growth hormone release. | Br Med J | 1973 | https://conductscience.org/library/papers/4717426 | PubMed |
| 13 | 4397744 | Some 5-hydroxytryptamine-like actions of fenfluramine: a comparison with (+)-amphetamine and diethylpropion. | J Pharm Pharmacol | 1971 | https://conductscience.org/library/papers/4397744 | PubMed |
| 14 | 4580610 | A comparative trial of different regimens of fenfluramine and phentermine in obesity. | Practitioner | 1973 | https://conductscience.org/library/papers/4580610 | PubMed |
| 15 | 5062254 | Central nervous system effects of fenfluramine hydrochloride. | J Pharmacol Exp Ther | 1972 | https://conductscience.org/library/papers/5062254 | PubMed |
| 16 | 5058666 | The possible central stimulant mechanisms of some appetite suppressants. | S Afr Med J | 1972 | https://conductscience.org/library/papers/5058666 | PubMed |
| 17 | 4574871 | [Effects of fenfluramine-amphetamine combination on psychomotor activity]. | Vie Med Can Fr | 1973 | https://conductscience.org/library/papers/4574871 | PubMed |
| 18 | 14327709 | CARDIOVASCULAR AND AUTONOMIC EFFECTS OF FENFLURAMINE HYDROCHLORIDE. | J Pharm Pharmacol | 1965 | https://conductscience.org/library/papers/14327709 | PubMed |
| 19 | 5146832 | Thermogenic properties of norfenfluramine. | Int J Biometeorol | 1971 | https://conductscience.org/library/papers/5146832 | PubMed |
| 20 | 4601613 | Fenfluramine in the management of obesity. | Br J Clin Pract | 1973 | https://conductscience.org/library/papers/4601613 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 179 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41152558 | The 'Obesity First' approach: Redefining the future of healthcare. | Indian J Gastroenterol | 2026 | https://conductscience.org/library/papers/41152558 | PubMed |
| 39318014 | Mobilizing Stockpile of Nature: Phytochemicals, Herbal Extracts, and Dietary Supplements for Managing Metabolic Diseases with Concentric Focus on Obesity. | Endocr Metab Immune Disord Drug Targets | 2025 | https://conductscience.org/library/papers/39318014 | PubMed |
| 38250648 | Pharmacological strategies for appetite modulation in eating disorders: a narrative review. | Consort Psychiatr | 2023 | https://conductscience.org/library/papers/38250648 | PubMed |
| 36853503 | Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis. | Neurol Ther | 2023 | https://conductscience.org/library/papers/36853503 | PubMed |
| 35892309 | Targeting skeletal muscle mitochondrial health in obesity. | Clin Sci (Lond) | 2022 | https://conductscience.org/library/papers/35892309 | PubMed |
| 34815532 | Anti-obesity drug discovery: advances and challenges. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/34815532 | PubMed |
| 33078386 | Fenfluramine HCl (Fintepla® ) provides long-term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open-label extension study. | Epilepsia | 2020 | https://conductscience.org/library/papers/33078386 | PubMed |
| 33040605 | Neurochemical regulators of food behavior for pharmacological treatment of obesity: current status and future prospects. | Future Med Chem | 2020 | https://conductscience.org/library/papers/33040605 | PubMed |
| 26106644 | A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone). | ScientificWorldJournal | 2015 | https://conductscience.org/library/papers/26106644 | PubMed |
| 22123816 | Hypothalamic Ahi1 mediates feeding behavior through interaction with 5-HT2C receptor. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22123816 | PubMed |
| 19505264 | Serotonergic drugs and valvular heart disease. | Expert Opin Drug Saf | 2009 | https://conductscience.org/library/papers/19505264 | PubMed |
| 17209663 | Serotonergic drugs : effects on appetite expression and use for the treatment of obesity. | Drugs | 2007 | https://conductscience.org/library/papers/17209663 | PubMed |
| 16569079 | Safety of drug therapies used for weight loss and treatment of obesity. | Drug Saf | 2006 | https://conductscience.org/library/papers/16569079 | PubMed |
| 8935804 | 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats. | Psychopharmacology (Berl) | 1996 | https://conductscience.org/library/papers/8935804 | PubMed |
| 8561960 | The nature of d,l-fenfluramine-induced 5-HT reuptake transporter loss in rats. | Mol Neurobiol | 1995 | https://conductscience.org/library/papers/8561960 | PubMed |
| 8280518 | Primary pulmonary hypertension and fenfluramine use. | Br Heart J | 1993 | https://conductscience.org/library/papers/8280518 | PubMed |
| 7621854 | Pulmonary hypertension and dexfenfluramine. | Eur J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/7621854 | PubMed |
| 7284682 | The effect of fenfluramine on the microstructure of feeding and drinking in the rat. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/7284682 | PubMed |
| 6431469 | Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement. | Psychopharmacology (Berl) | 1984 | https://conductscience.org/library/papers/6431469 | PubMed |
| 6289860 | The effects of fenfluramine on in vitro platelet aggregation. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6289860 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/765100
GET https://conductscience.org/api/papers/v1/765100/references?page=2